SCHEMBL2784576

SCHEMBL2784576

C[C@@H]1C[C@H]2OC(=O)[C@@]3(C)CCC[C@@](C)([C@@H]23)[C@@]1(O)CCc1ccoc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ USP2 O75604 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ SULT1E1 P49888 1/20 0.40
▸ ERAP1 Q9NZ08 2/20 0.36
▸ OPRK1 P41145 2/20 0.33
▸ TTL Q8NG68 1/20 0.33
▸ NR1H4 Q96RI1 2/20 0.32
▸ GAA P10253 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ PTPN1 P18031 1/20 0.30
▸ CDC25A P30304 1/20 0.30
▸ DUSP3 P51452 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26472020 1.00 ALDH1A1 (0.55) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL17301626 0.88 ALDH1A1 (0.50) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL30525934 0.83 ALDH1A1 (0.47) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL4460072 0.83 ALDH1A1 (0.61) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL17305097 0.78 PLA2G2A (0.33) ALDH1A1MAPT
SCHEMBL26472022 0.77 ALDH1A1 (0.53) ALDH1A1MAPTUSP2CYP3A4HSD17B10
Marrubenol SCHEMBL4450048 0.77 ALDH1A1 (0.53) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL19766903 0.75 ALDH1A1 (0.51) ALDH1A1MAPTUSP2CYP3A4HSD17B10
Rotundifuran SCHEMBL6233092 0.75 ALDH1A1 (0.56) ALDH1A1MAPTUSP2CYP3A4HSD17B10
SCHEMBL20035948 0.75 TTL (0.32) TTL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658087-A1 ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE PMI Nutrition, LLC (US) 2025-12-10 — — EP claimed
US-20250243302-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-07-31 — — US claimed
WO-2025129179-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-06-19 — — WO claimed
US-20250098710-A1 FEED ADDITIVE COMPOSITIONS AND METHODS PMI NUTRITION LLC (US) 2025-03-27 — — US claimed
US-12193457-B2 Feed additive compositions and methods PMI NUTRITION, LLC (US) 2025-01-14 — — US claimed
US-20240268416-A1 ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE PMI NUTRITION LLC (US) 2024-08-15 — — US claimed
WO-2024163291-A1 ANIMAL FEED ADDITIVE COMPOSITIONS AND METHODS OF USE PMI NUTRITION, LLC (US) 2024-08-08 — — WO claimed
EP-4408188-A1 FEED ADDITIVE COMPOSITIONS AND METHODS PMI Nutrition, LLC (US) 2024-08-07 — — EP claimed
CN-118175934-A Feed additive composition and method 普密艾营养有限公司 2024-06-11 — — CN claimed
US-20230381135-A1 COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME ELEONOR (BE) 2023-11-30 — — US claimed
EP-4048720-A1 MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME The Procter & Gamble Company (US) 2022-08-31 — — EP claimed
CN-114555681-A Multilayer dissolvable solid article comprising a coating composition and method of making the same 宝洁公司 2022-05-27 — — CN claimed
WO-2022079090-A1 COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME TILMAN SA (BE) 2022-04-21 — — WO claimed
EP-3246000-A1 SEPARABLE CAPSULE FOR SPRINKLING APPLICATIONS Capsugel Belgium NV (BE) 2017-11-22 — — EP claimed
EP-2179647-B1 Pipe including repellent REHAU AG & CO (DE) 2015-01-28 — — EP claimed
EP-2179647-A1 Pipe including repellent Rehau Ag + Co (DE) 2010-04-28 — — EP claimed
EP-1915166-B1 MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD PURANOX MEDICAL B V (NL) 2009-05-20 — — EP claimed
US-20080305192-A1 Marrubiin and Composition For Reducing Snoring, Package and Method PURANOX MEDICAL B.V. (NL) 2008-12-11 — — US claimed
EP-1915166-A2 MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD Puranox Medical B.V. (NL) 2008-04-30 — — EP claimed
WO-2007018432-A2 MARRUBIIN AND COMPOSITION FOR REDUCING SNORING, PACKAGE AND METHOD PURANOX MEDICAL B.V. (NL) 2007-02-15 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305192-A1 Marrubiin and Composition For Reducing Snoring, Package and Method NISCH, UTRN, MTPN ALDH1A1 1660/4885MAPT 4300/4885USP2 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback